tiprankstipranks
Chemed (DE:CXM)
NYSE:CXM
Germany Market

Chemed (CXM) Earnings Dates, Call Summary & Reports

2 Followers

Earnings Data

Report Date
Jul 28, 2026
After Close (Confirmed)
Period Ending
2026 (Q2)
Consensus EPS Forecast
4.92
Last Year’s EPS
3.75
Same Quarter Last Year
Based on 2 Analysts Ratings

Earnings Call Summary

Q1 2026
Earnings Call Date:Apr 23, 2026|
% Change Since:
|
Earnings Call Sentiment|Positive
The call presented strong performance and outlook improvements driven primarily by VITAS — higher admissions, modest revenue and margin gains, a sizable addition to Florida cap cushion, and upward revisions to full-year ADC, revenue growth and adjusted EBITDA margin. Roto-Rooter showed early signs of stabilization in core residential services and strategic franchise acquisitions, but faces near-term headwinds: elevated paid marketing costs, weather-related lost revenue, water restoration pricing disruptions and a notable YoY decline in Roto-Rooter EBITDA and margins. On balance, VITAS’ outperformance and the company’s raised guidance outweigh Roto-Rooter’s challenges, producing a constructive overall view for the year while acknowledging execution risks at Roto-Rooter.
Company Guidance
Chemed updated its fiscal 2026 guidance after a stronger‑than‑expected Q1 at VITAS: full‑year ADC growth was raised to 4.5%–5.5% (from 3.5%–4%), revenue growth excluding the Medicare Cap was increased to 6.5%–7.5% (from 5.5%–6.5%), and consolidated adjusted EBITDA margin excluding the Medicare Cap is now expected at 18.0%–18.5% (vs. prior 17.5%–18.5%); Roto‑Rooter revenue growth guidance remains 3.0%–3.5% but its estimated adjusted EBITDA margin was trimmed to 21.5%–22.5% (from 22.5%–23%) primarily due to elevated marketing spend. Management projects adjusted diluted EPS of $20.00–$24.75 for 2026 (originally $23.25–$24.25)—a midpoint the company stated is a 13% increase versus 2025 adjusted EPS of $21.55—and the guidance assumes a 24.5% effective tax rate on adjusted earnings and a diluted share count of 13.6 million shares.
VITAS Admissions and ADC Growth
Admissions totaled 19,394 in Q1 2026, a 6.9% increase year-over-year. Average daily census (ADC) was 22,723, up 2.2% year-over-year, and full-year ADC growth guidance was raised to 4.5%–5.5% (from 3.5%–4%).
VITAS Revenue and Margin Strength
VITAS net revenue was $420.0 million in Q1 2026, up 3.1% versus prior year. Average revenue per day improved to $210.62 (+146 basis points). Adjusted EBITDA (excluding Medicare Cap) was $70.8 million (+0.6% YoY) with an adjusted EBITDA margin of 16.8%.
Improved Financial Position in Florida
VITAS added over $32.5 million to cap cushion in the Florida combined program in Q1 2026 and management stated the 2025 Florida cap issue is behind them; no Florida combined program cap limitation is anticipated for fiscal 2026.
Raised Full-Year Company Guidance
Company-wide revenue growth excluding Medicare Cap revised to 6.5%–7.5% (from 5.5%–6.5%). Revised adjusted EBITDA margin (ex-Cap) raised to 18.0%–18.5% (from 17.5%–18.5%). Updated full-year adjusted EPS guidance of $20.00–$24.75 (management said midpoint represents a 13% increase from 2025 adjusted EPS of $21.55).
Roto-Rooter Signs of Recovery in Core Residential Services
For the first time since Q4 2022, Roto-Rooter saw increases in residential plumbing and residential sewer & drain revenue in Q1 2026. Total leads rose 3.3% YoY and paid leads increased 18.7% YoY (paid leads comprised 53.4% of leads vs 46.5% prior year).
Operational Improvements and Strategic Acquisitions
Centralization of water restoration billing/collections improved write-offs by $1.5 million versus Q1 2025. Company repurchased two franchise territories (San Francisco and Fort Worth) for ~$20.6 million; these are expected to add $5.0–$5.5 million of revenue for the remainder of 2026 and are immediately accretive to earnings.

Chemed (DE:CXM) Earnings, Revenues Date & History

The upcoming earnings date is based on a company’s previous reporting, and may be updated when the actual date is announced

DE:CXM Earnings History

Report Date
Fiscal Quarter
Forecast / EPS
Last Year's EPS
EPS YoY Change
Press Release
Slides
Play Transcript
Jul 28, 2026
2026 (Q2)
4.92 / -
3.749
Apr 23, 2026
2026 (Q1)
4.66 / 4.96
4.9430.36% (+0.02)
Feb 25, 2026
2025 (Q4)
6.17 / 5.64
5.997-6.00% (-0.36)
Oct 31, 2025
2025 (Q3)
4.71 / 4.63
4.952-6.56% (-0.32)
Jun 30, 2025
2025 (Q2)
4.50 / 3.75
4.803-21.94% (-1.05)
Apr 23, 2025
2025 (Q1)
4.87 / 4.94
4.5658.27% (+0.38)
Feb 26, 2025
2024 (Q4)
5.96 / 6.00
5.7953.48% (+0.20)
Oct 29, 2024
2024 (Q3)
4.96 / 4.95
4.6716.02% (+0.28)
Jul 24, 2024
2024 (Q2)
4.91 / 4.80
4.13516.14% (+0.67)
Apr 24, 2024
2024 (Q1)
4.81 / 4.57
4.2327.88% (+0.33)
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed

DE:CXM Earnings-Related Price Changes

Report Date
Price 1 Day Before
Price 1 Day After
Percentage Change
Apr 23, 2026
€315.56€343.53+8.86%
Feb 25, 2026
€393.46€339.53-13.71%
Oct 31, 2025
€384.45€368.52-4.15%
Jun 30, 2025
€465.47€405.80-12.82%
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.

FAQ

When does Chemed (DE:CXM) report earnings?
Chemed (DE:CXM) is schdueled to report earning on Jul 28, 2026, After Close (Confirmed).
    What is Chemed (DE:CXM) earnings time?
    Chemed (DE:CXM) earnings time is at Jul 28, 2026, After Close (Confirmed).
      Where can I see when companies are reporting earnings?
      You can see which companies are reporting today on our designated earnings calendar.
        What companies are reporting earnings today?
        You can see a list of the companies which are reporting today on TipRanks earnings calendar.
          What is the P/E ratio of Chemed stock?
          The P/E ratio of Chemed is N/A.
            What is DE:CXM EPS forecast?
            DE:CXM EPS forecast for the fiscal quarter 2026 (Q2) is 4.92.